Google
BDX 株価分析 — Becton Dickinson and Company (Healthcare >> Medical Instruments & Supplies)
BDX に関するよくある質問
BDXのPER（株価収益率）は？
Becton Dickinson and Company（BDX）は現在PER 32.46倍で取引されています。
BDXのROE（自己資本利益率）は？
Becton Dickinson and CompanyのROEは4.72%です。
BDXの配当利回りは？
Becton Dickinson and Companyの配当利回りは2.48%です。
BDXの品質スコア（Quality Score）は？
当社のAIはBDXの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
BDXは今が買い時ですか？
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
BDXはどのセクターに属しますか？
Becton Dickinson and CompanyはHealthcare >> Medical Instruments & Suppliesセクターに分類されます（NYSE市場）
BDX AI Analysis Summary
Our AI summary for BDX: Becton Dickinson and Company (NYSE), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 32.46, ROE of 4.72%, a dividend yield of 2.48%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 165.62
Price
0.17
(0.10%)
Day Change
|
|
|---|
BDX, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
2442
|
| Magic Formula Rank by ROE |
2442
|
| Magic Formula Rank by ROIC |
2631
|
| Price | 165.62 |
| PBV / Sector |
1.90 / 3.37
|
| Earning Per Share | 4.11 |
| PE / Sector |
32.46 / 44.25
|
| PEG or PE/Growth / Sector |
-29.78 / -1.35
|
| Average 1M Daily Value |
223.83 M
GREAT
|
| Average 1W Daily Value |
254.21 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
58% |
| ポイントになる統計 |
|
54% |
| 配当 |
|
41% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:32 |
| Symbol | BDX |
| Name | BECTON DICKINSON AND COMPANY |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NYSE |
| Listed Shares | 275.54 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 45,833.39 / 16,159.14 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880
Phone: 201 847 6800
Website: https://www.bd.com
Employees: 60,000
Description: Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
